ClinicalTrials.gg
CompletedNCT07896525Updated Nov 2, 2026

Generative AI Simulated Patients Versus Expert Demonstration Videos for Psychiatric Interview Training in Occupational Therapy Students

An interventional study of Generative AI simulated patient and Expert demonstration video in Clinical Competence, Communication Skills and Self Efficacy, sponsored by Chang Gung Memorial Hospital. Completed at 1 site in Taiwan. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-02.

Sponsored by Chang Gung Memorial Hospital · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 1 year 1 month after the study started (first participant enrolled Sep 2025, registered Oct 2026).
Updated Oct 27, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
53
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this study is to compare two methods for teaching psychiatric work-history interviewing to third-year occupational therapy students: practice with a generative AI simulated patient and an expert demonstration video. The main questions it aims to answer are:

  1. Which teaching method leads to better interview performance in an objective structured clinical examination (OSCE) with a standardized patient?
  2. How do the two methods affect students' interview self-efficacy?
  3. How do students evaluate the two methods, and which learning sequence do they prefer?

Students enrolled in a required vocational rehabilitation course were randomly assigned to one of two sequences. In the first teaching week, one sequence practiced interviewing a GPT-4o-based simulated patient (a 35-year-old person with schizophrenia), and the other watched and discussed an expert demonstration interview of the same case. Both groups completed a 9-minute standardized-patient OSCE on the same day. In the following week, the two sequences crossed over to the other method. Interview self-efficacy was measured before teaching, after the first method, and after the second method.

Read the detailed description

Design: Randomized two-period, two-sequence crossover trial embedded in the required course "Vocational Rehabilitation and Work Capacity Evaluation Practicum" (Department of Occupational Therapy, Chang Gung University). Only the teaching method in two course weeks (Week 6 and Week 7) differed between groups; all other course content and schedule were identical.

Interventions: The two methods used the same case script and were matched for teaching time. (1) Generative AI simulated patient: students conducted one-on-one, repeatable practice interviews with a GPT-4o-based simulated patient portraying a 35-year-old person with schizophrenia; brief automated feedback was provided after the conversation. (2) Expert demonstration video: a clinical expert recorded a demonstration interview of the same case, which students watched followed by instructor-led discussion.

Sequence 1: AI simulated patient in Week 6, expert video in Week 7. Sequence 2: expert video in Week 6, AI simulated patient in Week 7.

Primary outcome: OSCE interview performance immediately after the first-period teaching session (Week 6), before crossover. The OSCE used a standardized patient, a 9-minute interview followed by a written case summary, and a 15-item rubric (4-point scale; domains: establishing a therapeutic relationship, gathering a complete work history, discussing work expectations; total score 60). Examiners were blinded to students' teaching group.

Secondary outcomes: a 10-item interview self-efficacy questionnaire (5-point scale) administered at T1 (before teaching), T2 (after the first method, before crossover) and T3 (after the second method); an anonymous questionnaire comparing the two methods and asking preferred learning sequence, administered after students had experienced both methods; and an end-of-course reflection questionnaire in which students retrospectively rated their confidence at different course stages.

Students could not be blinded to the teaching method. Consent for use of course data in research was obtained separately and did not affect course grades.

02

Conditions studied

  • Clinical Competence
  • Communication Skills
  • Self Efficacy

Browse trials for

Keywords

  • generative artificial intelligence
  • virtual simulated patient
  • OSCE
  • occupational therapy education
  • psychiatric interview
  • crossover
03

In context

Communication

719 studies on the registry are indexed under Communication; 159 are open to participants now.

This study's enrollment of 53 is below the median of 144 across 571 interventional studies indexed under Communication.

Browse Communication studies →

Lead sponsor

Chang Gung Memorial Hospital is the lead sponsor of 1,096 studies on the registry; 239 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Third-year undergraduate students in the Department of Occupational Therapy, Chang Gung University, enrolled in the required course "Vocational Rehabilitation and Work Capacity Evaluation Practicum" in the 2025 fall semester
  • Provided written for the use of course data in research

Exclusion criteria

Exclusion Criteria:

* Declined consent for research use of their data (these students still participated in all course activities as usual)

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
53 participants (actual)

Study arms

  • Experimental
    Sequence 1: AI simulated patient, then expert video

    Period 1 (Week 6): practice with the generative AI simulated patient, followed by the OSCE on the same day. Period 2 (Week 7): crossover to the expert demonstration video.

    Behavioral: Generative AI simulated patient · Behavioral: Expert demonstration video

  • Experimental
    Sequence 2: expert video, then AI simulated patient

    Period 1 (Week 6): expert demonstration video with instructor-led discussion, followed by the OSCE on the same day. Period 2 (Week 7): crossover to practice with the generative AI simulated patient.

    Behavioral: Generative AI simulated patient · Behavioral: Expert demonstration video

Interventions

  • BehavioralGenerative AI simulated patient

    One-on-one, repeatable practice interviews with a GPT-4o-based simulated patient portraying a 35-year-old person with schizophrenia, using the same case script as the expert video and matched for teaching time. Brief automated feedback was provided after the conversation.

  • BehavioralExpert demonstration video

    A clinical expert's recorded demonstration interview of the same schizophrenia case, viewed by students and followed by instructor-led discussion; matched to the AI simulated patient session for teaching time and case content.

06

What researchers measure

Primary outcomes

  1. OSCE interview performance score

    Psychiatric work-history interview performance with a standardized patient, rated by examiners blinded to the teaching group using a 15-item rubric on a 4-point scale (1 = needs improvement to 4 = excellent) across three domains: establishing a therapeutic relationship, gathering a complete work history, and discussing work expectations. Total score range 15-60; higher scores indicate better performance.

    Time frame: Immediately after the Period 1 teaching session (same day, course Week 6), before crossover

Secondary outcomes

  1. Interview self-efficacy

    Psychiatric Interview Self-Efficacy Questionnaire (study-specific, 10 items), assessing confidence in conducting psychiatric work-history interviews, rated on a 5-point scale. Total score range 10 to 50; higher scores indicate greater interview self-efficacy.

    Time frame: T1: before teaching (Week 5); T2: after Period 1, before crossover (Week 6); T3: after Period 2 (Week 7)

  2. Student evaluation of the two teaching methods and preferred learning sequence

    Teaching Method Evaluation Questionnaire (study-specific, anonymous), administered after students had experienced both teaching methods. Eight parallel statements on the learning experience (e.g., clarity of instruction, a safe environment in which to make mistakes, usefulness of feedback) were rated separately for each teaching method on a 5-point Likert scale (1 = strongly disagree to 5 = strongly agree). Total score range 8 to 40 for each method; higher scores indicate a more favorable evaluation. Four forced-choice items comparing the two methods and asking the preferred learning sequence are reported descriptively as the number of students choosing each option.

    Time frame: After students had experienced both methods (Week 7)

Other outcomes

  1. End-of-course retrospective reflection on interview confidence

    End-of-Course Retrospective Confidence Reflection Questionnaire (study-specific, exploratory), administered as an end-of-course reflection activity. Students retrospectively rated their psychiatric interview confidence at seven course stages (from before any practice, through each teaching method, to before and after their first real-client interview and the end of the course) on a visual analogue-type numeric rating scale from 1 (lowest confidence) to 10 (highest confidence). Score range 1 to 10 at each stage; higher scores indicate greater confidence. Items on the learning resource recalled during real-client interviews and the preferred learning sequence are reported descriptively as the number of students choosing each option.

    Time frame: End of course (approximately 10 weeks after the teaching sessions)

07

Study locations

1 site
  • Chang Gung University
    Taoyuan, 333, Taiwan
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be publicly shared because participants did not consent to data sharing beyond the research team, as approved by the Institutional Review Board of Chang Gung Medical Foundation. De-identified data may be made available from the principal investigator upon reasonable request and with IRB approval.

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2025 to primary completion in Oct 2025, 0 months.

Of 390 non-industry interventional studies with no phase under Communication, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 36. This study's 0 months is below that.

Counting every sponsor, half of 394 studies reached it within 18 months; a quarter within 6 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 21, 2026
First posted
Oct 27, 2026
StartActual
Sep 17, 2025
Primary completionActual
Oct 8, 2025
CompletionActual
Dec 10, 2025
Last update
Nov 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Secondary outcomes
3 description edited
What changed in the outcomes
  • DescriptionInterview self-efficacy: how it is measured was reworded
  • DescriptionStudent evaluation of the two teaching methods and preferred learning sequence: how it is measured was reworded
  • Descriptionother outcomeEnd-of-course retrospective reflection on interview confidence: how it is measured was reworded
Nov 2, 2026
Registered
First appeared on the registry
Oct 27, 2026
Show all 2 updates
  1. Nov 2, 2026
    Secondary outcomes 3 description edited
    What changed in the outcomes
    • DescriptionInterview self-efficacy: how it is measured was reworded
    • DescriptionStudent evaluation of the two teaching methods and preferred learning sequence: how it is measured was reworded
    • Descriptionother outcomeEnd-of-course retrospective reflection on interview confidence: how it is measured was reworded
  2. Oct 27, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07896525
Collaborators
Chang Gung University, Ministry of Education, Taiwan
Responsible party
Poyu Chen (Assistant Professor, Chang Gung University) — Principal investigator
First posted
Oct 27, 2026
Start date
Sep 17, 2025
Primary completion
Oct 8, 2025
Completion
Dec 10, 2025
Last update
Nov 2, 2026

Study contacts

Poyu Chen, PhD
principal investigator · Chang Gung University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion